Abstract: The present invention relates to novel hydrogenases isolated from novel hyperthermophilic strains belonging to Thermococcus spp., genes encoding the hydrogenases, and methods of producing hydrogen using strains having the genes. According to the hydrogen production methods of the invention, a large amount of hydrogen can be produced merely by culturing the strains in specific culture conditions. Thus, the methods of the invention have advantages in that they are more economic and efficient than existing hydrogen production methods and can produce hydrogen even at high temperature.

Abstract: In a video encoder, pixel values of a macro-block are processed to determine an activity measure indicative of the type of content in the macro-block. Several techniques are employed for determining the activity measure of a macro-block. In an embodiment, a default quantization scale for quantizing a macro-block is modified based on the activity measure of the macro-block. In another embodiment, the macro-block is classified into one of multiple classes based on its activity measure. The default quantization scale for quantizing the macro-block is modified based on the classification of the macro-block. In yet another embodiment, an encoding mode to be used for encoding a macro-block is also determined on the basis of the class of the macro-block. Several of the techniques exploit the fact that the human visual system (HVS) has different sensitivities in perceiving a (rendered) macro-block or video frame, depending on the type of macro-block content.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of asthma comprising Wogonin as an active ingredient. The Wogonin of the present invention is excellent not only in relieving airway hypersensitivity that causes asthma in vivo, in inhibiting reactive oxygen species generation in the airway, and in inhibiting the infiltration of inflammatory cells in the bronchus, but also in inhibiting the generation of IgE in serum and bronchoalveolar lavage fluid, and in inhibiting the expressions of Th2 cytokines in the lung. Therefore, the Wogonin of the present invention can be effectively used as a composition for the prevention, treatment, or improvement of asthma.

Abstract: Provided are an identity (ID)-based encryption and signature method and a terminal that use an ID of a transmitter or a receiver as a part of the filename or the extension of a file transmitted to the receiver by the transmitter. Accordingly, it is possible to enable a user to visually recognize that the file has been provided with security. Also, it is possible to designate an associated program for the extension, and the user can easily decrypt or verify the file through the designated associated program.

Abstract: A method for encoding a video sequence in a scalable video encoder is provided that includes selecting a first search window configuration for coding a current picture of the video sequence in an enhancement layer encoder of the scalable video encoder based on motion vectors generated by a reference layer encoder when encoding the current picture, and coding the current picture in the enhancement layer encoder using the first search window configuration.

Abstract: A method for encoding a video sequence in a scalable video encoder to generate a scalable bitstream is provided that includes encoding the video sequence in a first layer encoder of the scalable video encoder to generate a first sub-bitstream, encoding the video sequence in a second layer encoder of the scalable video encoder to generate a second sub-bitstream, wherein portions of the video sequence being encoded in the second layer encoder are predicted using reference portions of the video sequence encoded in the first layer encoder, combining the first sub-bitstream and the second sub-bitstream to generate the scalable bitstream, and signaling in the scalable bitstream an indication of a maximum decoded picture buffer (DPB) size needed for decoding the second sub-bitstream and the first sub-bitstream when the second sub-bitstream is a target sub-bitstream for decoding.

Abstract: A method for encoding a video sequence in a scalable video encoder to generate a scalable bitstream is provided that includes encoding the video sequence in a first layer encoder of the scalable video encoder to generate a first sub-bitstream, encoding the video sequence in a second layer encoder of the scalable video encoder to generate a second sub-bitstream, wherein portions of the video sequence being encoded in the second layer encoder are predicted using reference portions of the video sequence encoded in the first layer encoder, combining the first sub-bitstream and the second sub-bitstream in the scalable bitstream, and signaling an indication of a highest temporal level of the first sub-bitstream comprising at least one of the reference portions in the scalable bitstream.

Abstract: For coding at least one region of interest within an image of multiple views, disparities are identified between the multiple views. In response to the disparities, the at least one region of interest is identified. The at least one region of interest is encoded at lower quantization relative to a remainder of the image. The remainder of the image is encoded at higher quantization relative to the at least one region of interest.

Abstract: The present invention relates to novel hydrogenases isolated from novel hyperthermophilic strains belonging to Thermococcus spp., genes encoding the hydrogenases, and methods of producing hydrogen using strains having the genes. According to the hydrogen production methods of the invention, a large amount of hydrogen can be produced merely by culturing the strains in specific culture conditions. Thus, the methods of the invention have advantages in that they are more economic and efficient than existing hydrogen production methods and can produce hydrogen even at high temperature.

Abstract: Disclosed is a pharmaceutical composition for the prophylaxis and therapy of inflammatory diseases, allergic diseases, or asthma, comprising a velvet apple (Diospyros blancoi A. DC.) extract as an active ingredient. Having the inhibitory activity against the nuclear translocation of NF-?B, whose level is rapidly elevated in response to inflammatory stimuli, the velvet apple extract can suppress the production of NO and PGE2, the expression of iNOS and COX-2, and the release of IL-1? and TNF-?, and can significantly down regulate Th2-mediated IL-4 and IL-13 production. In addition, the extract was found to inhibit the activation of eosinophils in bronchoalveolar lavage fluid, and to suppress the secretion of immunoglobulins and chemokines in bronchoalveolar lavage fluid and blood, as measured by in vivo tests on an ovalbumin-induced asthma mouse model. Therefore, the extract can be used in the method for preventing or treating various inflammatory disorders, allergic diseases, or asthma.

Abstract: Provided are an authentication method and an apparatus for the method. An authentication method includes generating, at a terminal, an identifier (ID)-based secret key using an ID of a user of the terminal and key generation factors exchanged with a server, encrypting, at the terminal, a password of the user using a symmetric key encryption algorithm taking the generated secret key as a symmetric key, and requesting authentication for the terminal user by transmitting the encrypted password to the server, and receiving, at the terminal, a response to the authentication request from the server.

Abstract: A display device includes a display panel including a gate line, a data line, and a pixel connected to the gate line and the data line, a signal controller generating control signals for driving the display panel including a data load timing signal, a gate driver applying a gate voltage to the gate line, and a data driver applying a data voltage to the data line according to the data load timing signal received from the signal controller, wherein the data load timing signal includes a first load signal pulse and a different second load signal pulse, and where a width of the second load signal pulse is larger than a width of the first load signal pulse.

Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma comprising the extract of Decaspermum fruticosum as an active ingredient. The extract of Decaspermum fruticosum of the present invention inhibited the increase of eosinophils in bronchoalveolar lavage fluid of the ovalbumin-induced asthma animal model, had the activity of inhibiting the secretions of immunoglobulin and chemokine (Eotaxin) in bronchoalveolar lavage fluid and blood, and inhibited the secretions of NO and TNF-? in macrophages. Therefore, the extract of Decaspermum fruticosum of the present invention can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma, and of a health functional food for the prevention and improvement of inflammatory disease or asthma.

Abstract: The present invention relates to novel hydrogenases isolated from novel hyperthermophilic strains belonging to Thermococcus spp., genes encoding the hydrogenases, and methods of producing hydrogen using strains having the genes. According to the hydrogen production methods of the invention, a large amount of hydrogen can be produced merely by culturing the strains in specific culture conditions. Thus, the methods of the invention have advantages in that they are more economic and efficient than existing hydrogen production methods and can produce hydrogen even at high temperature.

Abstract: A method for encoding a video sequence in a video encoder is provided that includes adapting a quantization parameter of a block of pixels in a picture of the video sequence based on a transform block size of the block of pixels to determine a final quantization parameter, and quantizing transform coefficients of the block of pixels using the final quantization parameter.

Abstract: The present invention relates to a skin moisturizing cosmetic composition that includes a pine resin extract, a Pinus Densiflora needle extract, and a Pinus Densiflora root extract, as active ingredients. More specifically, the present invention includes a pine resin extract, a Pinus Densiflora needle extract, and a Pinus Densiflora root extract, as active ingredients, and has advantageous effects of improving moisturizing activity on the skin and enhancing skin texture, skin clearness and skin contour.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating asthma, the composition containing styraxlignolide A or an aglycone thereof as an active ingredient. More particularly, styraxlignolide A compound is one separated from stems and barks of Styrax japonica, and styraxlignolide A or homoegonol, which is an aglycone of styraxlignolide A and which has improved safety, has the effect of attenuating weight loss and airway hyperresponsiveness, inhibiting the generation of reactive oxygen species in airway, inhibiting generation of IgE, TGF-?1, and IL-17 in the serum and bronchoalveolar lavage fluid, inhibiting endobronchial inflammatory cell infiltration, and inhibiting the formation of a mucous plug and subepithelial fibrosis in an asthma-induced mouse model. Therefore, styraxlignolide or homoegonol can be effectively used as the active ingredient of a pharmaceutical composition for preventing or treating bronchial asthma in which airway remodeling has progressed.

Abstract: The present invention relates to a cosmetic composition for massage, and more particularly, to a cosmetic composition for massage that provides a smooth rolling sensation even with a low oil content by controlling the ratio and content of polar and nonpolar oils and properly penetrates into the skin according to the control of the absorption rate by using a gum, which solves the problems with the existing massage compositions such as greasiness caused by a high content of oily ingredients and inconvenience associated with a need for cleansing the skin after use.

Abstract: The present invention relates to hydrogel particles coated with lipid, which are made from dispersing hydrogel particles in an organic solvent in which lipids are dissolved, and to a method for manufacturing same. Unlike the existing method for manufacturing hydrogel core vesicles, the present invention can effectively manufacture same by using an emulsification method, without involving the steps of chemical treatment of the surface of hydrogels or dilution, thereby facilitating mass production and preventing the decrease of drug encapsulation efficiency.

Abstract: Disclosed is a pharmaceutical composition for the prophylaxis and therapy of inflammatory diseases, allergic diseases, or asthma, comprising a velvet apple (Diospyros blancoi A. DC.) extract as an active ingredient. Having the inhibitory activity against the nuclear translocation of NF-?B, whose level is rapidly elevated in response to inflammatory stimuli, the velvet apple extract can suppress the production of NO and PGE2, the expression of iNOS and COX-2, and the release of IL-1? and TNF-?, and can significantly down regulate Th2-mediated IL-4 and IL-13 production. In addition, the extract was found to inhibit the activation of eosinophils in bronchoalveolar lavage fluid, and to suppress the secretion of immunoglobulins and chemokines in bronchoalveolar lavage fluid and blood, as measured by in vivo tests on an ovalbumin-induced asthma mouse model. Therefore, the extract can be used in the method for preventing or treating various inflammatory disorders, allergic diseases, or asthma.